Ambeed.cn

首页 / / / VEGF & VEGFR / Mouse VEGF 164 (P.Pichia)

Mouse VEGF 164 (P.Pichia) {[allProObj[0].p_purity_real_show]}

货号:A2925451 同义名: 重组小鼠VEGF 164蛋白(Tag free, P.Pichia) / Recombinant Mouse VEGF 164 (P.Pichia); Vascular endothelial growth factor A

Recombinant Mouse VEGF 164 (P.Pichia)是小鼠源重组蛋白,采用毕赤酵母表达系统,无标签。该蛋白为血管内皮生长因子(VEGF或VEGF-A)164亚型,属于PDGF/VEGF生长因子家族,具有稳定八半胱氨酸残基形成的结构,可结合内皮细胞上的VEGFR1和VEGFR2受体,主要通过VEGFR2介导促血管生成活性,参与胚胎发育及成年期血管新生与血管形成,也影响哺乳期血管通透性调控。

Mouse VEGF 164 (P.Pichia) 化学结构 CAS号:N/A
Mouse VEGF 164 (P.Pichia) 化学结构
CAS号:N/A
Mouse VEGF 164 (P.Pichia) 3D分子结构
CAS号:N/A
Mouse VEGF 164 (P.Pichia) 化学结构 CAS号:N/A
Mouse VEGF 164 (P.Pichia) 3D分子结构 CAS号:N/A
规格 价格 会员价 库存 数量
{[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Mouse VEGF 164 (P.Pichia) 纯度/质量文件 产品仅供科研

货号:A2925451 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Mouse VEGF 164 (P.Pichia) 生物活性

描述 Mouse Vascular endothelial growth factor (VEGF or VEGF­A), is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the PDGF/VEGF growth factor family that is characterized by a cystine knot structure formed by eight conserved cysteine residues. Alternately spliced isoforms of 120, 164 and 188 aa found in mouse. VEGF binds the type I transmembrane receptor tyrosine kinases VEGF R1 (also called Flt­1) and VEGF R2 (Flk­/KDR) on endothelial cells.Although affinity is highest for binding to VEGF R1, VEGF R2 appears to be the primary mediator of VEGF angiogenic activity. VEGF is required during embryogenesis to regulate the proliferation, migration, and survival of endothelial cells.It may play a role in increasing vascular permeability during lactation, when increased transport of molecules from the blood is required for efficient milk protein synthesis.
蛋白种属 Mouse
表达系统 P.Pichia
标签 Tag free
蛋白表达区间 Ala27-Arg190
蛋白编号 Q00731-2
内毒素 < 1 EU/µg as determined by LAL test.
剂型 干粉
剂型描述 Lyophilized from a 0.2 μm filtered solution of 20mM PB, 250mM NaCl, pH7.0.
复溶 Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
如要长期保存,建议使用含载体蛋白(如 0.1%BSA、10%FBS、5%HSA)的溶液进一步稀释,如果是做无血清培养或者动物体内实验时,细胞因子中不能含有BSA、FBS 和 HAS,可以使用海藻糖作为载体,然后分装冻存于-20℃至-80℃。
注:分装保存时建议使用低吸附的管子,并避免反复冻融;稀释分装浓度不低于 10μg/mL,分装体积不低于10μL。
分装后的蛋白在≤-20°C 下可稳定保存 3 个月。

Mouse VEGF 164 (P.Pichia) 技术信息

CAS号N/A
分子量 19.27 KDa
SMILES Code NONE
别名 重组小鼠VEGF 164蛋白(Tag free, P.Pichia) ;Recombinant Mouse VEGF 164 (P.Pichia); Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF; VEGFA; VEGFA164; VEGF164
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, store in freezer, under -20°C

AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。